Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 01, 2023 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Present at the 43rd Annual Cowen Health Care Conference

TORONTO, March 01, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
February 14, 2023 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 – Conference Call to Follow

TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
November 08, 2022 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Present at the 2022 Jefferies London Healthcare Conference

TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
November 03, 2022 16:05 ET | Source: Profound Medical Corp.

Profound Medical Announces Third Quarter 2022 Financial Results

TORONTO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
October 13, 2022 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to Follow

TORONTO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
September 26, 2022 08:00 ET | Source: Profound Medical Corp.

Four Year Follow-Up Data from Profound Medical’s TACT Pivotal Clinical Trial Confirm Durable and Stable Positive Trends Following Treatment with TULSA-PRO® of Men with Localized Prostate Cancer

TORONTO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
September 15, 2022 08:00 ET | Source: Profound Medical Corp.

Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth

TORONTO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
September 06, 2022 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Participate in September Investor Conferences

TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
September 02, 2022 12:05 ET | Source: Profound Medical Corp.

Profound Medical Provides TULSA-PRO® Reimbursement Update

TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
August 04, 2022 16:05 ET | Source: Profound Medical Corp.

Profound Medical Announces Second Quarter 2022 Financial Results

TORONTO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...